Actively Recruiting

Phase Not Applicable
Age: 45Years - 65Years
All Genders
Healthy Volunteers
ID07517887

Anti-aging Efficacy Study on One Cosmetic Product vs Untreated

Led by Amazentis SA · Updated on 2026-04-29

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

A

Amazentis SA

Lead Sponsor

S

SGS proderm GmbH

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of a topical cosmetic product containing Mitopure on skin health and aging. The study focuses on adults aged 45 to 65 with visible facial wrinkles and aims to assess improvements in skin hydration and other signs of aging over eight weeks. This study is sponsored by Amazentis SA and includes healthy volunteers. Participants will be randomly assigned to one of two groups: one group will apply the skin care product twice daily to half of the face (cosmetic routine arm), while the other group will not use the product (untreated control arm). The study monitors the impact of the product on various skin features, including wrinkle appearance, skin firmness, elasticity, barrier function, and overall clinical skin appearance. During the eight-week study, participants will visit the study site for evaluations including skin hydration measurements, clinical photography before and after treatment, and assessments of skin aging markers. Researchers will track product traits and changes in skin condition to understand the product's effects. The total duration of participation is eight weeks, with safety and skin health closely monitored throughout the trial.

CONDITIONS

Brief Title

Anti-aging Efficacy Study on One Cosmetic Product Containing Mitopure

Who Can Participate

Age: 45Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Written informed consent to participate in the study
  • Written informed consent for use of images for marketing purposes (applies to a subgroup)
  • Willingness to actively participate and attend scheduled visits
  • Female or male (approximately 10 to 15% with little facial hair)
  • Age between 45 and 65 years
  • Healthy skin in the test areas
  • Visible facial wrinkles graded 3 to 6 on the proderm wrinkle score
Not Eligible

You will not qualify if you...

  • Pregnancy or lactation for female participants
  • Drug or alcohol addiction
  • AIDS, HIV-positive status, or infectious hepatitis
  • Conditions excluding participation or affecting test evaluation
  • Recent participation or waiting period from cosmetic/pharmaceutical studies on test area
  • Active skin disease in the test area
  • Documented allergies to face or eye care products or ingredients
  • Diabetes mellitus
  • Cancer requiring treatment within last 2 years
  • Illnesses reducing physical fitness like unadjusted hypertension, asthma (unless symptom-free allergic), cardiovascular diseases
  • Epilepsy
  • Wounds, moles, tattoos, scars, irritated skin, excessive hair, or freckles on test area
  • Regular tanning bed use within 6 weeks before study
  • Use of topical medication on test area within 3 days before study
  • Use of immunosuppressive drugs or antihistamines within 7 days before and during study
  • Antibiotic therapy within 2 weeks before and during study
  • Cosmetic surgery on test area within last 2 years and during study
  • Cosmetic treatments like IPL, botox, chemical peel, dermabrasion within last 2 years and during study
  • Medical wrinkle reduction treatments within 2 weeks before and during study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 8 weeks

Participants in the experimental group apply the cosmetic skin care product twice daily to half of the face, while control participants do not apply the product.

Baseline visit and follow-up visits over 8 weeks

Trial Site Locations

Total: 1 location

1

SGS proderm GmbH

Schenefeld, Germany, 22869

Actively Recruiting

Loading map...

Research Team

B

Brad Currier, PhD

A

Anurag Singh, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here